MedTrace Logo

Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic

NCT04018222 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-09-16

No results posted yet for this study

Summary

This study is investigating the development of a diagnostic test intended to predict flares in patients with Systemic Lupus Erythematosus. Over a six-month period, the participant will donate blood samples for researchers to evaluate the types of proteins that are in their blood. During this time the participant will also visit a research physician to undergo a physical exam that will include an evaluation of the disease's level of activity. Questionnaires will be answered too, either via email, phone call, or a research app for android and iPhone devices. During this six-month period, if the participant experiences a lupus flare, they are strongly encouraged to visit the research physician to receive a complimentary medical evaluation.

Conditions

  • System; Lupus Erythematosus
  • Lupus Erythematosus
  • SLE
  • Lupus Flare

Sponsors & Collaborators

  • Oklahoma Center for the Advancement of Science and Technology

    collaborator OTHER

  • Progentec Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Eldon Jupe, Ph.D. · Progentec Diagnostics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018222 on ClinicalTrials.gov